ReviewFrontiers in immunology2023

Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy.

Farooq Riaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.